Mike's primary research interests are the discovery of genes with inherited mutations in the germline that cause cancer susceptibility, the discovery of somatically mutated genes in cancer that may provide targets for new drug discovery, and understanding the mutational processes and mutational signatures present in normal and cancer cells.